Martin Allen-Auerbach, MD

Martin Allen-Auerbach, MD

Clinical Professor, Department of Molecular and Medical Pharmacology
Medical Director, UCLA Positron Emission Tomography/Computed Tomography and Nuclear Medicine Services
Member, JCCC Community


English, German, Spanish, Swedish


Nuclear Medicine

Institutional Affiliation

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica



Nuclear Medicine, UCLA School of Medicine, 2002 - 2003
Research Fellowship, UCLA School of Medicine, 1997 - 1998


Internal Medicine, New York University Downtown Hospital, 1999 - 2000


MD, Universitat Wien Medizinische Fakultat, 1995


Internal Medicine, New York University Downtown Hospital, 2000 - 2002

Board Certification

Nuclear Medicine, American Board of Nuclear Medicine, 2003, 2012

Contact Information

Scientific Interests

Dr. Martin Allen-Auerbach serves as attending physician in nuclear medicine at the UCLA Santa Monica and Westwood hospitals. His active research includes clinical studies investigating the role of molecular imaging with PET/CT to gain insights into malignant disease processes and monitoring of cancer treatment.

Highlighted Publications

Allen-Auerbach M, de Vos S, Czernin J. PET/computed tomography and lymphoma. Radiol Clin North Am. 2013 Sep;51(5):833-44. doi: 10.1016/j.rcl.2013.05.004. Epub 2013 Jul 9.

Karantanis D, Kalkanis D, Allen-Auerbach M, Bogsrud TV, Subramaniam RM, Danielson A, Lowe VJ, Czernin J. Oncologic 18F-FDG PET/CT: referring physicians' point of view. J Nucl Med. 2012 Oct;53(10):1499-505. doi: 10.2967/jnumed.111.102228. Epub 2012 Aug 23.

Benz MR, Herrmann K, Walter F, Garon EB, Reckamp KL, Figlin R, Phelps ME, Weber WA, Czernin J, Allen-Auerbach MS. (18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib. J Nucl Med. 2011 Nov;52(11):1684-9. doi: 10.2967/jnumed.111.095257.